{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:58:30Z","timestamp":1793735910333,"version":"4.6.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T00:00:00Z","timestamp":1463184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T00:00:00Z","timestamp":1463184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006827","name":"Florida Department of Health","doi-asserted-by":"publisher","award":["5AZ08"],"award-info":[{"award-number":["5AZ08"]}],"id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health","doi-asserted-by":"publisher","award":["6AZ01"],"award-info":[{"award-number":["6AZ01"]}],"id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG051504"],"award-info":[{"award-number":["RF1AG051504"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG027924"],"award-info":[{"award-number":["R01AG027924"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG035355"],"award-info":[{"award-number":["R01AG035355"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG046205"],"award-info":[{"award-number":["R01AG046205"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 NS074969"],"award-info":[{"award-number":["P01 NS074969"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AG016574"],"award-info":[{"award-number":["P50 AG016574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AG016574"],"award-info":[{"award-number":["P50 AG016574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AG006786"],"award-info":[{"award-number":["U01AG006786"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG034676"],"award-info":[{"award-number":["R01AG034676"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS094137"],"award-info":[{"award-number":["R01NS094137"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00401-016-1580-y","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T17:16:10Z","timestamp":1463246170000},"page":"225-234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"132","author":[{"given":"Mitsuru","family":"Shinohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"DeTure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Atagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary D.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan M.","family":"Painter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Fryer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,14]]},"reference":[{"key":"1580_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ana.24135","volume":"75","author":"A Altmann","year":"2014","unstructured":"Altmann A, Tian L, Henderson VW, Greicius MD (2014) Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol 75:563\u2013573. doi:\n                    10.1002\/ana.24135","journal-title":"Ann Neurol"},{"key":"1580_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","volume":"11","author":"Alzheimer\u2019sAssociation","year":"2015","unstructured":"Alzheimer\u2019sAssociation (2015) 2015 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement 11:332\u2013384","journal-title":"Alzheimer\u2019s Dement"},{"key":"1580_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-005-1074-9","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J (2005) Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol 110:345\u2013359. doi:\n                    10.1007\/s00401-005-1074-9","journal-title":"Acta Neuropathol"},{"key":"1580_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-015-0273-8","author":"EN Bakker","year":"2016","unstructured":"Bakker EN, Bacskai BJ, Arbel-Ornath M, Aldea R, Bedussi B, Morris AW, Weller RO, Carare RO (2016) Lymphatic clearance of the brain: perivascular, paravascular and significance for neurodegenerative diseases. Cell Mol Neurobiol. doi:\n                    10.1007\/s10571-015-0273-8","journal-title":"Cell Mol Neurobiol"},{"key":"1580_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/archpsyc.62.6.685","volume":"62","author":"LL Barnes","year":"2005","unstructured":"Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62:685\u2013691. doi:\n                    10.1001\/archpsyc.62.6.685","journal-title":"Arch Gen Psychiatry"},{"key":"1580_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nj7398-407a","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J et al (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485:512\u2013516. doi:\n                    10.1038\/nature11087","journal-title":"Nature"},{"key":"1580_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/ana.22134","volume":"68","author":"A Biffi","year":"2010","unstructured":"Biffi A, Sonni A, Anderson CD, Kissela B, Jagiella JM, Schmidt H, Jimenez-Conde J, Hansen BM, Fernandez-Cadenas I, Cortellini L et al (2010) Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol 68:934\u2013943. doi:\n                    10.1002\/ana.22134","journal-title":"Ann Neurol"},{"key":"1580_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","volume":"10","author":"G Bu","year":"2009","unstructured":"Bu G (2009) Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333\u2013344. doi:\n                    10.1038\/nrn2620","journal-title":"Nat Rev Neurosci"},{"key":"1580_CR9","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1089\/jwh.2012.3789","volume":"21","author":"CL Carter","year":"2012","unstructured":"Carter CL, Resnick EM, Mallampalli M, Kalbarczyk A (2012) Sex and gender differences in Alzheimer\u2019s disease: recommendations for future research. J Womens Health (Larchmt) 21:1018\u20131023. doi:\n                    10.1089\/jwh.2012.3789","journal-title":"J Womens Health (Larchmt)"},{"key":"1580_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1196\/annals.1297.005","volume":"1019","author":"EH Corder","year":"2004","unstructured":"Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H (2004) The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci 1019:24\u201328. doi:\n                    10.1196\/annals.1297.005","journal-title":"Ann N Y Acad Sci"},{"key":"1580_CR11","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1161\/01.STR.0000014421.15948.67","volume":"33","author":"JC de la Torre","year":"2002","unstructured":"de la Torre JC (2002) Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33:1152\u20131162","journal-title":"Stroke"},{"key":"1580_CR12","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1212\/WNL.46.6.1592","volume":"46","author":"RJ Ellis","year":"1996","unstructured":"Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A (1996) Cerebral amyloid angiopathy in the brains of patients with Alzheimer\u2019s disease: the CERAD experience, part XV. Neurology 46:1592\u20131596","journal-title":"Neurology"},{"key":"1580_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/bpa.12221","volume":"25","author":"M Esiri","year":"2015","unstructured":"Esiri M, Chance S, Joachim C, Warden D, Smallwood A, Sloan C, Christie S, Wilcock G, Smith AD (2015) Cerebral amyloid angiopathy, subcortical white matter disease and dementia: literature review and study in OPTIMA. Brain Pathol 25:51\u201362. doi:\n                    10.1111\/bpa.12221","journal-title":"Brain Pathol"},{"key":"1580_CR14","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.neuroimage.2010.08.009","volume":"54","author":"N Filippini","year":"2011","unstructured":"Filippini N, Ebmeier KP, MacIntosh BJ, Trachtenberg AJ, Frisoni GB, Wilcock GK, Beckmann CF, Smith SM, Matthews PM, Mackay CE (2011) Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage 54:602\u2013610. doi:\n                    10.1016\/j.neuroimage.2010.08.009","journal-title":"Neuroimage"},{"key":"1580_CR15","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","volume":"25","author":"JD Fryer","year":"2005","unstructured":"Fryer JD, Simmons K, Parsadanian M, Bales KR, Paul SM, Sullivan PM, Holtzman DM (2005) Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J Neurosci 25:2803\u20132810. doi:\n                    10.1523\/JNEUROSCI.5170-04.2005","journal-title":"J Neurosci"},{"key":"1580_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainres.2013.04.052","volume":"1519","author":"M Gahr","year":"2013","unstructured":"Gahr M, Nowak DA, Connemann BJ, Schonfeldt-Lecuona C (2013) Cerebral Amyloidal Angiopathy\u2014a disease with implications for neurology and psychiatry. Brain Res 1519:19\u201330. doi:\n                    10.1016\/j.brainres.2013.04.052","journal-title":"Brain Res"},{"key":"1580_CR17","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.1074\/jbc.270.13.7013","volume":"270","author":"SA Gravina","year":"1995","unstructured":"Gravina SA, Ho L, Eckman CB, Long KE, Otvos L Jr, Younkin LH, Suzuki N, Younkin SG (1995) Amyloid beta protein (A beta) in Alzheimer\u2019s disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem 270:7013\u20137016","journal-title":"J Biol Chem"},{"key":"1580_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1474-4422(14)70003-1","volume":"13","author":"SM Greenberg","year":"2014","unstructured":"Greenberg SM, Al-Shahi Salman R, Biessels GJ, van Buchem M, Cordonnier C, Lee JM, Montaner J, Schneider JA, Smith EE, Vernooij M et al (2014) Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol 13:419\u2013428. doi:\n                    10.1016\/S1474-4422(14)70003-1","journal-title":"Lancet Neurol"},{"key":"1580_CR19","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 41:1088\u20131093. doi:\n                    10.1038\/ng.440","journal-title":"Nat Genet"},{"key":"1580_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1750-3639.2006.tb00560.x","volume":"16","author":"MC Herzig","year":"2006","unstructured":"Herzig MC, Van Nostrand WE, Jucker M (2006) Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol 16:40\u201354","journal-title":"Brain Pathol"},{"key":"1580_CR21","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148:1204\u20131222. doi:\n                    10.1016\/j.cell.2012.02.040","journal-title":"Cell"},{"key":"1580_CR22","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Xu H, Bu G (2014) ApoE and Abeta in Alzheimer\u2019s disease: accidental encounters or partners? Neuron 81:740\u2013754. doi:\n                    10.1016\/j.neuron.2014.01.045","journal-title":"Neuron"},{"key":"1580_CR23","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1152\/japplphysiol.01095.2005","volume":"101","author":"DN Krause","year":"1985","unstructured":"Krause DN, Duckles SP (1985) Pelligrino DA (2006) Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol 101:1252\u20131261. doi:\n                    10.1152\/japplphysiol.01095.2005","journal-title":"J Appl Physiol"},{"key":"1580_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jmb.2011.11.047","volume":"421","author":"SL La Porte","year":"2012","unstructured":"La Porte SL, Bollini SS, Lanz TA, Abdiche YN, Rusnak AS, Ho WH, Kobayashi D, Harrabi O, Pappas D, Mina EW et al (2012) Structural basis of C-terminal beta-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer\u2019s disease. J Mol Biol 421:525\u2013536. doi:\n                    10.1016\/j.jmb.2011.11.047","journal-title":"J Mol Biol"},{"key":"1580_CR25","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 41:1094\u20131099. doi:\n                    10.1038\/ng.439","journal-title":"Nat Genet"},{"key":"1580_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106\u2013118. doi:\n                    10.1038\/nrneurol.2012.263","journal-title":"Nat Rev Neurol"},{"key":"1580_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jns.2007.01.054","volume":"257","author":"LF Maia","year":"2007","unstructured":"Maia LF, Mackenzie IR, Feldman HH (2007) Clinical phenotypes of cerebral amyloid angiopathy. J Neurol Sci 257:23\u201330. doi:\n                    10.1016\/j.jns.2007.01.054","journal-title":"J Neurol Sci"},{"key":"1580_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00005072-198601000-00007","volume":"45","author":"TI Mandybur","year":"1986","unstructured":"Mandybur TI (1986) Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol 45:79\u201390","journal-title":"J Neuropathol Exp Neurol"},{"key":"1580_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/abbi.1993.1112","volume":"301","author":"DL Miller","year":"1993","unstructured":"Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer\u2019s disease. Arch Biochem Biophys 301:41\u201352. doi:\n                    10.1006\/abbi.1993.1112","journal-title":"Arch Biochem Biophys"},{"key":"1580_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1555-z","author":"AW Morris","year":"2016","unstructured":"Morris AW, Sharp MM, Albargothy NJ, Fernandes R, Hawkes CA, Verma A, Weller RO, Carare RO (2016) Vascular basement membranes as pathways for the passage of fluid into and out of the brain. Acta Neuropathol. doi:\n                    10.1007\/s00401-016-1555-z","journal-title":"Acta Neuropathol"},{"key":"1580_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10:785\u2013796. doi:\n                    10.1016\/S1474-4422(11)70156-9","journal-title":"Lancet Neurol"},{"key":"1580_CR32","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/NEN.0b013e31829a25b9","volume":"72","author":"PT Nelson","year":"2013","unstructured":"Nelson PT, Pious NM, Jicha GA, Wilcock DM, Fardo DW, Estus S, Rebeck GW (2013) APOE-epsilon2 and APOE-epsilon4 correlate with increased amyloid accumulation in cerebral vasculature. J Neuropathol Exp Neurol 72:708\u2013715. doi:\n                    10.1097\/NEN.0b013e31829a25b9","journal-title":"J Neuropathol Exp Neurol"},{"key":"1580_CR33","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/ana.410410607","volume":"41","author":"JA Nicoll","year":"1997","unstructured":"Nicoll JA, Burnett C, Love S, Graham DI, Dewar D, Ironside JW, Stewart J, Vinters HV (1997) High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 41:716\u2013721. doi:\n                    10.1002\/ana.410410607","journal-title":"Ann Neurol"},{"key":"1580_CR34","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1161\/STROKEAHA.108.542894","volume":"40","author":"RE Petrea","year":"2009","unstructured":"Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA (2009) Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke 40:1032\u20131037. doi:\n                    10.1161\/STROKEAHA.108.542894","journal-title":"Stroke"},{"key":"1580_CR35","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1161\/STROKEAHA.113.001522","volume":"44","author":"Y Pu","year":"2013","unstructured":"Pu Y, Liu L, Wang Y, Zou X, Pan Y, Soo Y, Leung T, Zhao X, Wong KS (2013) Geographic and sex difference in the distribution of intracranial atherosclerosis in China. Stroke 44:2109\u20132114. doi:\n                    10.1161\/STROKEAHA.113.001522","journal-title":"Stroke"},{"key":"1580_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/jnnp-2013-306485","volume":"85","author":"K Rannikmae","year":"2014","unstructured":"Rannikmae K, Kalaria RN, Greenberg SM, Chui HC, Schmitt FA, Samarasekera N, Al-Shahi Salman R, Sudlow CL (2014) APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis. J Neurol Neurosurg Psychiatry 85:300\u2013305. doi:\n                    10.1136\/jnnp-2013-306485","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1580_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.brainresrev.2003.08.001","volume":"43","author":"AA Rensink","year":"2003","unstructured":"Rensink AA, de Waal RM, Kremer B, Verbeek MM (2003) Pathogenesis of cerebral amyloid angiopathy. Brain Res Brain Res Rev 43:207\u2013223","journal-title":"Brain Res Brain Res Rev"},{"key":"1580_CR38","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/jnen\/62.9.885","volume":"62","author":"T Revesz","year":"2003","unstructured":"Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, Holton JL (2003) Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 62:885\u2013898","journal-title":"J Neuropathol Exp Neurol"},{"key":"1580_CR39","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/jamaneurol.2014.681","volume":"71","author":"JM Ringman","year":"2014","unstructured":"Ringman JM, Sachs MC, Zhou Y, Monsell SE, Saver JL, Vinters HV (2014) Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease. JAMA Neurol 71:878\u2013883. doi:\n                    10.1001\/jamaneurol.2014.681","journal-title":"JAMA Neurol"},{"key":"1580_CR40","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:9649\u20139653","journal-title":"Proc Natl Acad Sci USA"},{"key":"1580_CR41","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1172\/JCI0216783","volume":"110","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ (2002) Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. J Clin Invest 110:1375\u20131381. doi:\n                    10.1172\/JCI16783","journal-title":"J Clin Invest"},{"key":"1580_CR42","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/brain\/awu046","volume":"137","author":"M Shinohara","year":"2014","unstructured":"Shinohara M, Fujioka S, Murray ME, Wojtas A, Baker M, Rovelet-Lecrux A, Rademakers R, Das P, Parisi JE, Graff-Radford NR et al (2014) Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer\u2019s disease. Brain 137:1533\u20131549. doi:\n                    10.1093\/brain\/awu046","journal-title":"Brain"},{"key":"1580_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-013-1086-9","volume":"125","author":"M Shinohara","year":"2013","unstructured":"Shinohara M, Petersen RC, Dickson DW, Bu G (2013) Brain regional correlation of amyloid-beta with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-beta accumulation. Acta Neuropathol 125:535\u2013547. doi:\n                    10.1007\/s00401-013-1086-9","journal-title":"Acta Neuropathol"},{"key":"1580_CR44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1750-3639.2009.00322.x","volume":"20","author":"V Soontornniyomkij","year":"2010","unstructured":"Soontornniyomkij V, Lynch MD, Mermash S, Pomakian J, Badkoobehi H, Clare R, Vinters HV (2010) Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol 20:459\u2013467. doi:\n                    10.1111\/j.1750-3639.2009.00322.x","journal-title":"Brain Pathol"},{"key":"1580_CR45","first-page":"452","volume":"145","author":"N Suzuki","year":"1994","unstructured":"Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y (1994) High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 145:452\u2013460","journal-title":"Am J Pathol"},{"key":"1580_CR46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-010-0707-9","volume":"120","author":"DR Thal","year":"2010","unstructured":"Thal DR, Papassotiropoulos A, Saido TC, Griffin WS, Mrak RE, Kolsch H, Del Tredici K, Attems J, Ghebremedhin E (2010) Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer\u2019s disease. Acta Neuropathol 120:169\u2013183. doi:\n                    10.1007\/s00401-010-0707-9","journal-title":"Acta Neuropathol"},{"key":"1580_CR47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/archneurol.2009.913","volume":"67","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty M, Beason-Held L, An Y, Kraut MA, Resnick SM (2010) APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch Neurol 67:93\u201398. doi:\n                    10.1001\/archneurol.2009.913","journal-title":"Arch Neurol"},{"key":"1580_CR48","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/01.STR.18.2.311","volume":"18","author":"HV Vinters","year":"1987","unstructured":"Vinters HV (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18:311\u2013324","journal-title":"Stroke"},{"key":"1580_CR49","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/01.STR.14.6.924","volume":"14","author":"HV Vinters","year":"1983","unstructured":"Vinters HV, Gilbert JJ (1983) Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14:924\u2013928","journal-title":"Stroke"},{"key":"1580_CR50","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","volume":"18","author":"RO Weller","year":"2008","unstructured":"Weller RO, Subash M, Preston SD, Mazanti I, Carare RO (2008) Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease. Brain Pathol 18:253\u2013266. doi:\n                    10.1111\/j.1750-3639.2008.00133.x","journal-title":"Brain Pathol"},{"key":"1580_CR51","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1001\/jamaneurol.2013.2152","volume":"70","author":"BV Zlokovic","year":"2013","unstructured":"Zlokovic BV (2013) Cerebrovascular effects of apolipoprotein e: implications for Alzheimer disease. JAMA Neurol 70:440\u2013444. doi:\n                    10.1001\/jamaneurol.2013.2152","journal-title":"JAMA Neurol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-016-1580-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-016-1580-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-016-1580-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-016-1580-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T12:43:30Z","timestamp":1589633010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-016-1580-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,14]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1007\/s00401-016-1580-y","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,14]]},"assertion":[{"value":"26 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"R. C. Petersen: Consultant to Roche, Inc., Merck, Inc., Genentech, Inc., Biogen, Inc., Eli Lilly and Co.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}